Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Salivary Gland Tumor”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Testing effectiveness (Phase 2)WithdrawnNCT00984217
What this trial is testing

Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies

Who this might be right for
Adenoma, PleomorphicMixed Salivary Gland TumorSalivary Gland Tumor, Mixed+1 more
University of Pittsburgh
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Testing effectiveness (Phase 2)Study completedNCT01220817
What this trial is testing

Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study

Who this might be right for
Recurrent Prostate Cancer
POM Wonderful LLC 104
Testing effectiveness (Phase 2)Study completedNCT00095563
What this trial is testing

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Who this might be right for
High-grade Salivary Gland CarcinomaHigh-grade Salivary Gland Mucoepidermoid CarcinomaLow-grade Salivary Gland Carcinoma+7 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)WithdrawnNCT01607866
What this trial is testing

Quadrant Versus Superficial Parotidectomy

Who this might be right for
Pleomorphic Adenoma of the Parotid Gland
Mansoura University
Large-scale testing (Phase 3)Study completedNCT01752634
What this trial is testing

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 397
Not applicableStudy completedNCT00851253
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Boston Medical Center 12
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableNo Longer AvailableNCT02090127
What this trial is testing

Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

Who this might be right for
Mullerian Mixed Tumor of Ovary
AVEO Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT00101075
What this trial is testing

Title XELOX FOR SALIVARY GLAND CANCERS

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00502203
What this trial is testing

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Who this might be right for
Mixed Tumor, Mullerian
M.D. Anderson Cancer Center 23
Not applicableStudy completedNCT01078402
What this trial is testing

EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries

Who this might be right for
Ankylosing Spondylitis (AS)Psoriatic Arthritis (PsARheumatoid Arthritis (RA
AbbVie (prior sponsor, Abbott) 809
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT00984074
What this trial is testing

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Abramson Cancer Center at Penn Medicine 3
Not applicableWithdrawnNCT00562341
What this trial is testing

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

Who this might be right for
ObesityProstate Cancer
Maimonides Medical Center
Not applicableEnded earlyNCT00911079
What this trial is testing

Pilot Study of a Catheter-based Ultrasound Hyperthermia System

Who this might be right for
Cervical CancerProstate Cancer
University of California, San Francisco 13
Large-scale testing (Phase 3)Study completedNCT01697384
What this trial is testing

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Endo USA Inc., a Keenova Therapeutics Company 138
Next Page